Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
90,283,479
-
Shares change
-
+335,176
-
Total reported value, excl. options
-
$1,542,093,372
-
Value change
-
+$61,590,148
-
Put/Call ratio
-
74%
-
Number of buys
-
105
-
Number of sells
-
105
-
Price
-
$17.08
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2023
As of 31 Dec 2023 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 90,283,479 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Darwin Global Management, Ltd., Pictet Asset Management Holding SA, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Opaleye Management Inc., and Paradigm Biocapital Advisors LP.
This table shows 228 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.